Time to act: A call for comprehensive responses to HIV in people who use drugs

The Lancet

Volumn 376, Issue 9740, 2010, Pages 551-563

  Beyrer, Chris ^a   Malinowska Sempruch, Kasia ^b   Kamarulzaman, Adeeba ^c   Kazatchkine, Michel ^d   Sidibe, Michel ^e   Strathdee, Steffanie A ^f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Open Society Institute   (Poland)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d TUBERCULOSIS AND MALARIA   (Switzerland)

^e UNAIDS   (Switzerland)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG ABUSE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RIGHTS; INFECTION RISK; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SUBSTITUTION THERAPY;

EID: 77956058280     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60928-2     Document Type: Review

References (68)

1. L Guiness, P Vickerman, Z Quayyum The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh Addiction 105 2010 319 328
2. P Vickerman, L Kumaranayake, O Balakireva The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine Sex Transm Dis 33 suppl 10 2006 S89 102
3. D Wolfe, MP Carrieri, D Shepard Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward Lancet 2010 10.1016/S0140-6736(10)60832-X published online July 20.
4. L Degenhardt, B Mathers, P Vickerman, T Rhodes, C Latkin, M Hickman Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed Lancet 2010 10.1016/S0140-6736(10)60742-8 published online July 20.
5. SA Strathdee, TB Hallett, N Bobrova HIV and risk environment for injecting drug users: the past, present, and future Lancet 2010 10.1016/S0140-6736(10)60743-X published online July 20.
6. FL Altice, A Kamarulzaman, VV Soriano, M Schechter, GH Friedland Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs Lancet 2010 10.1016/S0140-6736(10)60829-X published online July 20.
7. G Colfax, G-M Santos, P Chu Amphetamine-group substances and HIV Lancet 2010 10.1016/S0140-6736(10)60753-2 published online July 20.
8. R Jürgens, J Csete, JJ Amon, S Baral, C Beyrer People who use drugs, HIV, and human rights Lancet 2010 10.1016/S0140-6736(10)60830-6 published online July 20.
9. G Backman, P Hunt, R Khosla Health systems and the right to health: an assessment of 194 countries Lancet 372 2008 2047 2085
10. B Mathers, L Degenhardt, B Phillips for the 2007 Reference Group to the UN on HIV and Injecting Drug Use Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review Lancet 372 2008 1733 1745
11. J Kwon, J Iversen, L Maher, M Law, D Wilson The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model based analysis J Acquir Immune Defic Syndr 51 2009 462 469
12. C Van Den Berg, C Smit, G Van Brussel, R Coutinho, M Prins Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users Addiction 102 2007 1454
13. Le Vu S, Le Strat Y, Pillonel J, et al. Population-based HIV incidence in France, 2003 to 2008. 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA, USA; Feb 16-19, 2010. Paper 36LB.
14. E Wood, T Kerr, B Marshall Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study BMJ 338 2009 b1649
15. S Santibanez, R Garfein, A Swartzendruber, D Purcell, L Paxton, A Greenberg Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States J Urban Health 83 2006 86 100
16. C Todd, A Abed, S Strathdee HIV, HCV, and HBV infections and associated risk behavior in injecting drug users, Kabul, Afghanistan Emerg Infect Dis 13 2007 1327 1331
17. C Beyrer, Z Patel, JA Stachowiak Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan AIDS Res Hum Retroviruses 25 2009 853 860
18. UNAIDS AIDS epidemic update http://www.unaids.org/en/KnowledgeCentre/ HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp 2009 (accessed March 8, 2010).
19. BM Mathers, L Degenhardt, H Ali for the 2009 Reference to the UN on HIV and Injecting Drug Use HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage Lancet 375 2010 1014 1028
20. L Gelmon, P Kenya, F Oguya, B Cheluget, G Haile Kenya HIV prevention response and modes of transmission analysis http://www.unaidsrstesa.org/files/ u1/Kenya-MoT-Country-Synthesis-Report-22Mar09.pdf March, 2009 (accessed April 15, 2010).
21. LM Niccolai, IS Shcherbakova, OV Toussova, AP Kozlov, R Heimer The potential for bridging of HIV transmission in the Russian Federation: sex risk behaviors and HIV prevalence among drug users (DUs) and their non-DU sex partners J Urban Health 86 suppl 1 2009 131 143
22. WHO Assessment of compulsory treatment of people who use drugs in Cambodia, China, Malaysia and Viet Nam: an application of selected human rights principles http://www.who.int/hiv/pub/idu/assess-treatment-users-asia/en/index. html 2009 (accessed March 8, 2010).
23. Grover A. The right to health, the rights-based approach, towards decriminalization (Oct 27, 2009). International Conference on Realising the Rights to Health and Development for All; Hanoi, Vietnam; Oct 26-29, 2009.
24. S Baral, G Trapence, F Motimedi HIV prevalence, risks for HIV infection, and human rights among men who have sex with men (MSM) in Malawi, Namibia, and Botswana PLoS One 4 2009 e4997
25. Johnston L, Dahoma M, Holman A, et al. HIV infection and related risk behavior among men who have sex with men in Zanzibar, Tanzania. XVII International AIDS Conference; Mexico City, Mexico; Aug 3-8, 2008. Abstract WEPE742.
26. UNODC World drug report http://www.unodc.org/unodc/en/data-and-analysis/ WDR-2009.html 2009 (accessed March 8, 2010).
27. UNODC Addiction, crime, and insurgency: the transnational threat of Afghan opium http://www.unodc.org/documents/data-and-analysis/Afghanistan/ Afghan-Opium-Trade-2009-web.pdf (accessed March 8, 2010).
28. UNODC Anti-Narcotics Force Afghanistan opium survey http://www.unodc.org/ documents/crop-monitoring/Afghanistan/Afghanistan-opium-survey-2009-summary.pdf 2009 (accessed March 8, 2010).
29. P Kheirandish, S Seyedalinaghi, M Hosseini Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran J Acquir Immune Defic Syndr 53 2010 273 275
30. UNODC Regional Office for Central Asia Illicit drug trends in central Asia http://www.unodc.org/documents/regional/central-asia/Illicit20Drug20Trends- Central20Asia-final.pdf April, 2008 (accessed May 4, 2010).
31. A Kamarulzaman, SM Saifuddeen Islam and harm reduction Int J Drug Policy 21 2010 115 118
32. K Tee, O Pybus, XJ Li Temporal and spatial dynamics of human immunodeficiency virus type 1 circulating recombinant forms 08-BC and 07-BC in Asia J Virol 82 2008 9206 9215
33. S Tovanabutra, G Kijak, C Beyrer Identification of CRF34-01B, a second circulating recombinant form unrelated to and more complex than CRF15-01B, among injecting drug users in northern Thailand AIDS Res Hum Retroviruses 23 2007 829 833
34. Michael N. RV 144 update: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thai adults (oral presention, session 23). 17th Conference on Retroviruses and Opportunistic Infections; San Fransisco, CA, USA; Feb 16-19, 2010. Paper 74.
35. S Tovanabutra, C Beyrer, S Sakkhachornphop The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002 AIDS Res Hum Retroviruses 20 2004 465 475
36. D Lohman, R Schleifer, J Amon Access to pain treatment as a human right BMC Med 8 2010 8
37. WHO Access to Controlled Medications Programme Improving access to medications controlled under international drug conventions http://www.eapcnet. org/download/forOrganisations/PSM.AccessToControlledMedications.pdf 2009 (accessed March 8, 2010).
38. Human Rights Watch Human Rights Watch interview with Dr Weru of Nairobi Hospice, Nairobi, Kenya. "Please, do not make us suffer any more..." Human Rights Watch Access to pain treatment as a human right 2009 Human Rights Watch New York
39. Pain and Policy Studies Group WHO Collaborating Center for Policy and Communications in Cancer Care Opioid availability: eastern Europe and central Eurasion. Palliative care in cancer 2005 Open Society Institute Budapest, Hungary http://www.painpolicy.wisc.edu/publicat/monograp/hungary05.pdf (accessed April 5, 2010).
40. UNODC Commission on Narcotic Drugs Report on the fifty-third session (2 December 2009 and 8-12 March 2010) 2010 UN Office on Drugs and Crime Vienna
41. D Stuckler, S Basu, M McKee, L King Mass incarceration can explain population increases in TB and multidrug-resistant TB in European and central Asian countries Proc Natl Acad Sci USA 105 2008 13280 13285
42. M Mauer, R King Uneven justice: state rates of incarceration by race and ethnicity 2007 The Sentencing Project Washington DC
43. Anon. Bad science and bad policy. New York Times (New York), March 3, 2010.
44. MR Khan, IA Doherty, VJ Schoenbach, EM Taylor, MW Epperson, AA Adimora Incarceration and HIV-risk sex partnerships among men in the United States J Urban Health 86 2009 584 601
45. K Choopanya, DC Des Jarlais, S Vanichseni Incarceration and risk for HIV infection among IDU in Bangkok J Acquir Immune Defic Syndr 29 2002 86 94
46. D Werb, T Kerr, W Small, K Li, J Montaner, E Wood HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies J Public Health (Oxf) 30 2008 126 132
47. J Amon Where darkness knows no limits: incarceration, ill-treatment and forced labor as drug rehabilitation in China 2010 Human Rights Watch New York
48. T Rhodes, M Simic Transition and the HIV risk environment BMJ 331 2005 220 223 2005
49. GM Lucas, BA Mullen, PJ Weidle, S Hader, ME McCaul, RD Moore Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups Clin Infect Dis 42 2006 1628 1635
50. A Palepu, NJ Horton, N Tibbetts, S Meli, JH Samet Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment Addiction 99 2004 361 368
51. A Palepu, MW Tyndall, R Joy, T Kerr, E Wood, N Press Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy Drug Alcohol Depend 84 2006 188 194
52. WHO Achieving balance in national opioids control policy: guidelines for assessment http://www.painpolicy.wisc.edu/publicat/00whoabi/00whoabi.htm 2000 (accessed April 25, 2010).
53. WHO Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach http://whqlibdoc.who.int/ publications/2008/9789241596930-eng.pdf 2008 (accessed March 10, 2010).
54. J Kates, E Lief, C Avila Financing the response to AIDS in low and middle income countries: international assistance from the G8, European Commission and other donor Governments http://www.unaidscaribbean.org/uploads/ group20of20eight20funding20for20hiv.pdf 2008 (accessed March 10, 2010).
55. UNAIDS Financial resources required to achieve universal access to HIV prevention, treatment, care and support http://data.unaids.org/pub/Report/2007/ JC1678-Fin-Res-Req-en.pdf 2007 (accessed March 10, 2010).
56. E Wood, D Werb, M Kazatchkine Vienna Declaration: a call for evidence-based drug policies Lancet 2010 10.1016/S0140-6736(10)60958-0 published online July 20, 2010.
57. K Dolan, B Kite, E Black, C Aceijas, GV Stimson for the Reference Group on HIV/AIDS Prevention and Care Among Injecting Drug Users in Developing and Transitional Countries HIV in prison in low-income and middle-income countries Lancet Infect Dis 7 2008 32 41
58. O Balakiryeva, L Gusak, H Dovbakh Evaluation of the size of most-at-risk populations vulnerable to HIV infection in Ukraine: analytic report based on the research results 2006 International Charitable Foundation "International HIV/AIDS Alliance in Ukraine" Kyiv
59. US Department of State Background note: Ukraine http://www.state.gov/r/ pa/ei/bgn/3211.htm 2009 (accessed May 14, 2010).
60. WJ Sabol, HC West Prisoners in 2007 2008 US Bureau of Justice Washington DC
61. C Mumola, J Karberg Drug use and dependence, state and federal prisoners, 2004 2006 US Department of Justice Washington DC
62. R Walmsley World prison population list 2009 Q2 International Centre for Prison Studies, King's College London
63. WHO UNODC UNODC WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users http://www.who.int/hiv/pub/idu/targetsetting/en/index.html 2009 (accessed March 10, 2010).
64. CDC CDC trials of pre-exposure prophylaxis for HIV prevention http://www.cdc.gov/hiv/prep/resources/factsheets/index.htm (accessed June 11, 2010).
65. C Beyrer, S Baral, A Shaboltas The feasibility of HIV vaccine efficacy trials among Russian injection drug users Vaccine 25 2007 7014 7016
66. N Crofts, D Herkt A history of peer-based drug-user groups in Australia J Drug Issues 25 1995 599 626
67. E Wood, T Kerr, P Spittal, W Small, M Tyndall, M O'Shaughnessy An external evaluation of a peer-run "unsanctioned" syringe exchange program J Urban Health 80 2003 455 464
68. International Network of People Who Use Drugs Press Release: Give peace a chance, stop the failed war on drugs http://www.druguserpeaceinitiative.org/ images/INPUDPressReleaseCND.pdf 2009 (accessed March 9, 2010).